RE:RE:RE:Gilles No doubt that Gilles is not your typcial TSXV promotional CEO.
Consider that if he was and missed out on those timelines as he needed to pivot or faced unforeseen issues (ie. a black swan event like COVID); who does that benefit if the stock soared on promotion then dropped due to missed milestones? While speculators and MOMOs players who sold on a promotional spike won't be around, those who held on would be become a large number of disgruntled shareholders. That really isn't creating shareholder value.
When investing in companies, esp. microcaps, the number one thing to look at first is management. If management doesn't fit your requirements, then you should have passed on Ceapro as an investment for yourself.
Lastly, it was mentioned before that a Mickey Mouse deal for PGX was rejected and that companies that were interested in licensing PGX wholly instead of specific appications of (ie. NCC) were also rebuffed (the latter I consider "selling the farm"). They believe they have adequate cash flow to support daily operations and R&D and will grow PGX related revenues under more favorable terms.